Silo Pharma (SILO) Quarterly EPS earnings growth

Silo Pharma - graphic logo of issuer SILO

Silo Pharma, Inc. (SILO) is developing psychedelic treatments for Alzheimer's to restore cognitive functions. The quarterly EPS growth rate reflects the market reaction to the portfolio diversification with PTSD medications. Sales potential for fibromyalgia treatment following FDA approval supports financial stability, with the metric value standing at 89.10, which determines the company's current profit trajectory.

Silo Pharma, Inc. (SILO) - Year-over-year earnings per one share growth for the last 12 months from 04/28/2023 to 11/16/2026

Summary analytical data breakdowns for Silo Pharma, Inc. (SILO)

- share price and consensus valuation forecast:
Analysis of all company metrics:Silo Pharma, Inc.
Manufactured product of Silo Pharma Inc.

For the innovative psychedelic therapy developer Silo Pharma, Inc. (SILO), financial stability during R&D cycles is evidenced by the dynamics of net earnings per share. By analyzing quarterly EPS fluctuations, investors assess the percentage change in profit relative to the previous period, which helps identify hidden imbalances and confirm the company's ability to monetize its unique nanotechnologies to achieve high margins.

Direct competitors

ALKS (alkermes.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Avadel Pharma (AVDL)|ATAI (atai.life) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months GH Research PLC (GHRS)|Quarterly EPS earnings growth MNMD|CMPS (COMPASS Pathways PLC) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months lbpharma.us LBRX|Bright Minds Biosciences Inc (DRUG) - Earnings per share growth in annualized terms for the last twelve months|VNDA: Year-over-year net earnings per share growth for the last 12 months|Cybin Inc (CYBN) - Year-over-year net earnings per share growth for the last 12 months|Alto Neuroscience (ANRO) - Year-over-year earnings per share growth for the last twelve months|NRx Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cingulate|chinapharmaholdings.com (CPHI) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth CMND|Psyence Biomedical Ltd. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months SciSparc Ltd SPRC|Seelos Therapeutics Inc. (SEEL) - Earnings per share growth in annualized terms for the last twelve months|VRPX: Year-over-year net earnings per share growth for the last 12 months|KRTX - Quarterly EPS earnings growth